The Journal of clinical endocrinology and metabolism
GLP- 1 Receptor Agonists in Patients with Cancer are Associated with Reduced All-Cause Mortality and Hospitalization.
Aditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora, Ruthvik Sunil Kumar, Gagandeep Singh, Katy K Tsai, Zoe Quandt
Published: 202610.1210/clinem/dgaf703
Abstract
BACKGROUND: GLP- 1 RA have been reported to decrease cancer incidence, but less is known about their potential in patients with active cancer. Preclinical studies have demonstrated that GLP-1 RA inhibit progression of solid tumor malignancies via dow…
Preview only. Read the full abstract at the source